From Innovation to Activation:

New & Emerging Drug Therapies and How to Gain Access to the Best Treatments Available

Our June 7, 2014 Toronto Educational Forum, featuring Lymphoma Canada's Scientific Advisory Board Chair, Dr. John Kuruvilla of Princess Margaret Hospital, and Patient Advocate Louise Binder.  Dr. Kuruvilla speaks on the newest treatments for Hodgkin lymphoma, non-Hodgkin lymphoma, and Chronic Lymphocytic Leukemia (CLL).  Afterwards, renowned patient advocate Louise Binder discusses treatment access issues.

View the two webcasts from June 7, 2014 below.